Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis

Clinical Chemistry and Laboratory Medicine

Volumn 58, Issue 7, 2020, Pages 1021-1028

  Henry, Brandon Michael ^a   De Oliveira, Maria Helena Santos ^b   Benoit, Stefanie ^a,c   Plebani, Mario ^d   Lippi, Giuseppe ^e  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

clinical chemistry; coronavirus; COVID 19

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT RESPIRATORY DISTRESS SYNDROME; BIBLIOGRAPHIC DATABASE; BIOCHEMICAL ANALYSIS; CORONAVIRUS DISEASE 2019; DISEASE SEVERITY; FERRITIN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; META ANALYSIS; MORTALITY; PLATELET COUNT; PRIORITY JOURNAL; REVIEW; SURVIVOR; SYSTEMATIC REVIEW; BETACORONAVIRUS; CORONAVIRINAE; CORONAVIRUS INFECTION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PANDEMIC; PATHOGENICITY; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VIRUS PNEUMONIA;

BETACORONAVIRUS; BIOMARKERS; CORONAVIRUS; CORONAVIRUS INFECTIONS; COVID-19; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; PANDEMICS; PLATELET COUNT; PNEUMONIA, VIRAL; RISK FACTORS; SARS-COV-2; SEVERITY OF ILLNESS INDEX;

EID: 85083502926     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2020-0369     Document Type: Review

References (30)

1. World Health Organization-China Joint Mission. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed March 1, 2020.
2. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta 2020. doi: 10.1016/j.cca.2020.03.022.
3. Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta 2020. doi: 10.1016/j.cca.2020.03.004.
4. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
5. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557-60.
6. Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:E005.
7. Chen C, Chen C, Jiangtao Y, Ning Z, Jianping Z, Daowen W. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Chin J Cardiol 2020;48:E008.
8. Fan BE, Chong VC, Chan SS, Lim GH, Lim KG, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020. doi: 10.1002/ajh.25774.
9. Guan W-J, Ni Z-Y, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. doi: 10.1056/NEJMoa2002032.
10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
11. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63:364-74.
12. Liu W, Tao Z-W, Lei W, Ming-Li Y, Kui L, Ling Z, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J 2020. doi: 10.1097/CM9.0000000000000775.
13. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa248.
14. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020. doi: 10.1007/s00134-020-05991-x.
15. Qu R, Ling Y, Zhang Y-H, Wei LY, Chen X, Li X, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19. J Med Virol 2020. doi: 10.1002/jmv.25767.
16. Liu M, He P, Liu M, Wang X, Li F, Chen S, et al. [Analysis of clinical characteristics of 30 cases of new coronavirus pneumonia in medical staff]. Chin J Tuberculosis Respir Dis 2020;43:209-14.
17. Qian G-Q, Yang N-B, Ding F, Ma AH, Wang ZY, Shen YF, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. Q J Med 2020. doi: 10.1093/qjmed/hcaa089.
18. Tianxin X, Liu J, Xu F, Cheng N, Liu Y, Qian K. [Analysis of clinical features of 49 patients with new type of coronavirus pneumonia in Jiangxi]. Chin J Respir Crit Care 2020. doi: 10.7507/1671-6205.202002070.
19. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc 2020. doi: 10.1001/jama.2020.1585.
20. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa272.
21. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. doi: 10.1001/jamainternmed.2020.0994.
22. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med 2020. doi:10.1016/S2213-2600(20)30079-5.
23. Young BE, Ong SW, Kalimuddin S, Kalimuddin S, Low JG, Tan SY, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. J Am Med Assoc 2020. doi: 10.1001/jama.2020.3204.
24. Yun L, Yixiao L, Zhiping Q, et al. Clinical analysis of risk factors for severe patients with novel coronavirus pneumonia. Chin J Infect Dis 2020;38:E023. doi: 10.3760/cma.j.cn311365-20200211-00055.
25. Zhang J-J, Dong X, Cao Y-Y, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020. doi: 10.1111/all.14238.
26. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020.
27. He Z, Zhao C, Dong Q, Zhuang H, Song S, Peng G, et al. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis 2005;9:323-30.
28. Henry B. COVID-19, ECMO, and lymphopenia: A word of caution. Lancet Respir Med 2020.
29. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107:1062-73.
30. Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol 2007;170:1136-47.